Started this discussion. Last reply by alan wolman Feb 11, 2014. 2 Replies 3 Favorites
Sarepta Therapeutics Announces Eteplirsen Demonstrates Stability on Pulmonary Function Tests through 120 Weeks in Phase IIb Study in Duchenne Muscular DystrophyRead more: …Continue
© 2022 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
Comment Wall
You need to be a member of PPMD Community to add comments!
Join PPMD Community